These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26569327)

  • 1. Expression and Function of CD44 in Epithelial Ovarian Carcinoma.
    Sacks JD; Barbolina MV
    Biomolecules; 2015 Nov; 5(4):3051-66. PubMed ID: 26569327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadotropin stimulation of MLS human epithelial ovarian carcinoma cells augments cell adhesion mediated by CD44 and by alpha(v)-integrin.
    Schiffenbauer YS; Meir G; Maoz M; Even-Ram SC; Bar-Shavit R; Neeman M
    Gynecol Oncol; 2002 Feb; 84(2):296-302. PubMed ID: 11812090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells.
    Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C
    Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic role of the cancer stem cell marker CD44 in ovarian cancer: a meta-analysis.
    Shi YY; Jiang H
    Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27525945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD44 expression indicates favorable prognosis in epithelial ovarian cancer.
    Sillanpää S; Anttila MA; Voutilainen K; Tammi RH; Tammi MI; Saarikoski SV; Kosma VM
    Clin Cancer Res; 2003 Nov; 9(14):5318-24. PubMed ID: 14614016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer stem-like cell marker CD44 promotes bone metastases by enhancing tumorigenicity, cell motility, and hyaluronan production.
    Hiraga T; Ito S; Nakamura H
    Cancer Res; 2013 Jul; 73(13):4112-22. PubMed ID: 23633482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of tumorigenesis and oestrogen receptor-alpha expression by cell culture conditions in a stem cell-derived breast epithelial cell line.
    Wang KH; Kao AP; Chang CC; Lee JN; Chai CY; Hou MF; Liu CM; Tsai EM
    Biol Cell; 2010 Jan; 102(3):159-72. PubMed ID: 19895368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells.
    Baba T; Convery PA; Matsumura N; Whitaker RS; Kondoh E; Perry T; Huang Z; Bentley RC; Mori S; Fujii S; Marks JR; Berchuck A; Murphy SK
    Oncogene; 2009 Jan; 28(2):209-18. PubMed ID: 18836486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 Regulates Formation of Spheroids and Controls Organ-Specific Metastatic Colonization in Epithelial Ovarian Carcinoma.
    Sacks Suarez J; Gurler Main H; Muralidhar GG; Elfituri O; Xu HL; Kajdacsy-Balla AA; Barbolina MV
    Mol Cancer Res; 2019 Sep; 17(9):1801-1814. PubMed ID: 31147393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and significance of CD44, CD47 and c-met in ovarian clear cell carcinoma.
    Wang H; Tan M; Zhang S; Li X; Gao J; Zhang D; Hao Y; Gao S; Liu J; Lin B
    Int J Mol Sci; 2015 Feb; 16(2):3391-404. PubMed ID: 25658794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of alternative splicing of CD44 in cancer.
    Prochazka L; Tesarik R; Turanek J
    Cell Signal; 2014 Oct; 26(10):2234-9. PubMed ID: 25025570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian cancer stem cells: working towards the root of stemness.
    Foster R; Buckanovich RJ; Rueda BR
    Cancer Lett; 2013 Sep; 338(1):147-57. PubMed ID: 23138176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
    Yan Y; Zuo X; Wei D
    Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of PLGA nanoparticles carrying shRNA against focal adhesion kinase and CD44 results in enhanced antitumor effects against ovarian cancer.
    Zou L; Song X; Yi T; Li S; Deng H; Chen X; Li Z; Bai Y; Zhong Q; Wei Y; Zhao X
    Cancer Gene Ther; 2013 Apr; 20(4):242-50. PubMed ID: 23492823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44(high)CD24(low) molecular signature determines the Cancer Stem Cell and EMT phenotype in Oral Squamous Cell Carcinoma.
    Ghuwalewala S; Ghatak D; Das P; Dey S; Sarkar S; Alam N; Panda CK; Roychoudhury S
    Stem Cell Res; 2016 Mar; 16(2):405-17. PubMed ID: 26926234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.
    Idowu MO; Kmieciak M; Dumur C; Burton RS; Grimes MM; Powers CN; Manjili MH
    Hum Pathol; 2012 Mar; 43(3):364-73. PubMed ID: 21835433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44 integrates signaling in normal stem cell, cancer stem cell and (pre)metastatic niches.
    Williams K; Motiani K; Giridhar PV; Kasper S
    Exp Biol Med (Maywood); 2013 Mar; 238(3):324-38. PubMed ID: 23598979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance of the stemness in CD44(+) HCT-15 and HCT-116 human colon cancer cells requires miR-203 suppression.
    Ju SY; Chiou SH; Su Y
    Stem Cell Res; 2014 Jan; 12(1):86-100. PubMed ID: 24145190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CD44 standard and variant isoforms v5, v6 and v7 in human ovarian cancer cell lines.
    Stickeler E; Runnebaum IB; Möbus VJ; Kieback DG; Kreienberg R
    Anticancer Res; 1997; 17(3C):1871-6. PubMed ID: 9216637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the dual nature of CD44 in breast cancer progression.
    Louderbough JM; Schroeder JA
    Mol Cancer Res; 2011 Dec; 9(12):1573-86. PubMed ID: 21970856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.